Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)

Clinical trial NCT06860477 · RECRUITING

Trial details

NCT number: NCT06860477
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocellular Carcinoma

Start date: 2025-03-18
Primary completion: 2027-03-15
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.